phase 3_initiation
saveZhuhai Qiwei Biotechnology Co Ltd — QA-102 (Phase III Trial Initiation)
community read0 votes
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that